According to the 2015 ESC/ERS Guidelines, the presence of biallelic EIF2AK4 mutation was sufficient to confirm the diagnosis of PVOD without a histological confirmation. The gene discussed is EIF2AK4; the disease is pulmonary venoocclusive disease.